Reaktion #6331

ord-1f6e982b827e468188c3fc64dfc63777

Reaktionsgleichung

CC(=O)NCC1OC(=O)N2c3ccccc3CC12
N-[(9,9a-Dihydro-3-oxo-1H,3H-oxazolo[3,4-a]indol-1-yl)methyl]acetamide
O=C1CCC(=O)N1Br
N-bromosuccinimide
O=C(OOC(=O)c1ccccc1)c1ccccc1
benzoylperoxide
CC(=O)NCC1OC(=O)N2c3ccc(Br)cc3CC12
title compound
CC(=O)NCC1OC(=O)N2c3ccc(Br)cc3CC12
N-[(7-bromo-9,9a-dihydro-3-oxo-1H,3H-oxazolo[3,4-a]indol-1-yl)methyl]acetamide

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeThen a small portion is removed
  2. 2
    EinengenThe mixture was then concentrated under reduced pressure

Vorschrift

(±) (1S,9aS/1R,9aR) N-[(9,9a-Dihydro-3-oxo-1H,3H-oxazolo[3,4-a]indol-1-yl)methyl]acetamide (X, diastereomer B, [SS,RR-trans], EXAMPLE 11, 299 mg) is dissolved in acetonitrile (10 ml). To this mixture N-bromosuccinimide (235 mg) and a catalytic amount of benzoylperoxide are added as solids to the mixture at 20°-25°. The mixture is stirred at 20°-25° in a sealed flask over night. Then a small portion is removed and examined by NMR. The mixture was then concentrated under reduced pressure to give the title compound, NMR (CDCl3, 300 MHz) 7.30, 6.49, 4.63, 4.52, 3.72, 3.29, 3.12, 2.76 and 2.06 δ.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05247090uspto-grants-1993_09